CA2269661A1 - Cassettes d'encapsidation d'aav activables par la recombinase servant a la production de vecteurs d'aav - Google Patents
Cassettes d'encapsidation d'aav activables par la recombinase servant a la production de vecteurs d'aav Download PDFInfo
- Publication number
- CA2269661A1 CA2269661A1 CA002269661A CA2269661A CA2269661A1 CA 2269661 A1 CA2269661 A1 CA 2269661A1 CA 002269661 A CA002269661 A CA 002269661A CA 2269661 A CA2269661 A CA 2269661A CA 2269661 A1 CA2269661 A1 CA 2269661A1
- Authority
- CA
- Canada
- Prior art keywords
- aav
- gene
- recombinase
- packaging
- ssr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4712—Cystic fibrosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4168996P | 1996-12-18 | 1996-12-18 | |
US60/041,689 | 1996-12-18 | ||
PCT/US1997/023018 WO1998027207A1 (fr) | 1996-12-18 | 1997-12-12 | Cassettes d'encapsidation d'aav activables par la recombinase servant a la production de vecteurs d'aav |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2269661A1 true CA2269661A1 (fr) | 1998-06-25 |
Family
ID=21917821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002269661A Abandoned CA2269661A1 (fr) | 1996-12-18 | 1997-12-12 | Cassettes d'encapsidation d'aav activables par la recombinase servant a la production de vecteurs d'aav |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0946723A1 (fr) |
JP (1) | JP2001506132A (fr) |
AU (1) | AU5603998A (fr) |
CA (1) | CA2269661A1 (fr) |
WO (1) | WO1998027207A1 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6924128B2 (en) | 1994-12-06 | 2005-08-02 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant AAV vectors |
US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
US6989264B2 (en) | 1997-09-05 | 2006-01-24 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
US6416992B1 (en) | 1998-10-13 | 2002-07-09 | Avigen, Inc. | Compositions and methods for producing recombinant adeno-associated virus |
US6893865B1 (en) | 1999-04-28 | 2005-05-17 | Targeted Genetics Corporation | Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles |
EP1939300A1 (fr) | 1999-05-28 | 2008-07-02 | Targeted Genetics Corporation | Procédés et compositions pour diminuer le niveau de facteur de nécrose de tumeur (TNF) pour des troubles associés au TNF |
US6537540B1 (en) | 1999-05-28 | 2003-03-25 | Targeted Genetics Corporation | Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
EP1916258B1 (fr) | 1999-08-09 | 2014-04-23 | Targeted Genetics Corporation | Améliorations de l'expression d'une séquence de nucléotides hétérologues à brin unique à partir de vecteurs viraux recombinants par la désignation de la séquence de manière à ce qu'elle forme des paires de bases intrabrins |
DE60039766D1 (de) | 1999-08-09 | 2008-09-18 | Targeted Genetics Corp | Terologen nukleotidsequenz von einem rekombinanten viralen vektor durch ausgestaltung der sequenz in einer art und weise, dass basenpaarungen innerhalb der sequenz entstehen |
DE19941186A1 (de) * | 1999-08-30 | 2001-03-01 | Peter Droege | Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen |
EP1134287A1 (fr) * | 2000-03-08 | 2001-09-19 | Universite De Geneve | Système pour contrôler l'expression d'un gène donné en utilisant un autre gène codant pour un polypeptide avec une activité recombinante |
JP2004536572A (ja) | 2001-02-23 | 2004-12-09 | セル・ジェネシス・インコーポレイテッド | 新規ベクター構築物 |
NL1017852C2 (nl) * | 2001-04-17 | 2002-10-29 | Multigen Holding S A | Recombinant nucleotidevolgorde welke codeert voor een gen. |
EP1587923B1 (fr) | 2003-01-22 | 2011-08-24 | Duke University | Constructions ameliorees permettant d'exprimer des polypeptides lysosomiaux |
JP2007521835A (ja) | 2004-02-10 | 2007-08-09 | トラスティーズ・オブ・ダートマウス・カレッジ | ニコチンアミドリボシドキナーゼ組成物およびそれらの使用方法 |
MX2011010097A (es) | 2009-03-27 | 2011-10-19 | Proyecto Biomedicina Cima Sl | Metodos y composiciones para el tratamiento de cirrosis y fibrosis hepatica. |
KR101835490B1 (ko) | 2009-05-02 | 2018-03-08 | 젠자임 코포레이션 | 신경변성 질환에 대한 유전자 요법 |
JP2014503173A (ja) | 2009-11-05 | 2014-02-13 | プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ | 制御された発現系 |
WO2012145509A2 (fr) | 2011-04-19 | 2012-10-26 | The Research Foundation Of State University Of New York | Séquences rep de virus adéno-associé, vecteurs, et virus |
US9163259B2 (en) | 2012-05-04 | 2015-10-20 | Novartis Ag | Viral vectors for the treatment of retinal dystrophy |
EP2981612B1 (fr) | 2013-04-04 | 2019-07-03 | Trustees of Dartmouth College | Compositions et procédés pour l'excision in vivo d'adn proviral de vih-1 |
WO2017081204A1 (fr) * | 2015-11-11 | 2017-05-18 | Targeted Transgenesis Limited | Expression de transgène sélective d'un tissu |
CN110914413A (zh) | 2017-02-17 | 2020-03-24 | 隆萨有限公司 | 产生腺相关病毒的哺乳动物细胞 |
US10610606B2 (en) | 2018-02-01 | 2020-04-07 | Homology Medicines, Inc. | Adeno-associated virus compositions for PAH gene transfer and methods of use thereof |
US11306329B2 (en) | 2018-02-19 | 2022-04-19 | City Of Hope | Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof |
MX2021010149A (es) | 2019-02-25 | 2021-09-14 | Novartis Ag | Composiciones y metodos para tratar la distrofia cristalina de bietti. |
EP3931335A2 (fr) | 2019-02-25 | 2022-01-05 | Novartis AG | Compositions et procédés pour traiter une dystrophie cristalline de bietti |
TW202140791A (zh) | 2020-01-13 | 2021-11-01 | 美商霍蒙拉奇醫藥公司 | 治療苯酮尿症之方法 |
CA3197726A1 (fr) | 2020-10-15 | 2022-04-21 | Simon Auslaender | Constructions d'acides nucleiques ameliorees pour activation de genes simultanee |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0796339A1 (fr) * | 1994-12-06 | 1997-09-24 | Targeted Genetics Corporation | Lignees cellulaires d'encapsidation utilisees pour la generation de titres hauts de vecteurs aav recombinants |
DE69631480T2 (de) * | 1995-08-03 | 2004-11-25 | Avigen Inc., Alameda | Helfersystem zur wirkungssteigerung der aav-vektorproduktion |
EP0950111A1 (fr) * | 1996-09-06 | 1999-10-20 | The Trustees Of The University Of Pennsylvania | Procede d'utilisation de cre-lox pour la production de virus adeno-associes de recombinaison |
-
1997
- 1997-12-12 CA CA002269661A patent/CA2269661A1/fr not_active Abandoned
- 1997-12-12 WO PCT/US1997/023018 patent/WO1998027207A1/fr not_active Application Discontinuation
- 1997-12-12 AU AU56039/98A patent/AU5603998A/en not_active Abandoned
- 1997-12-12 JP JP52788098A patent/JP2001506132A/ja active Pending
- 1997-12-12 EP EP97952436A patent/EP0946723A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0946723A1 (fr) | 1999-10-06 |
AU5603998A (en) | 1998-07-15 |
JP2001506132A (ja) | 2001-05-15 |
WO1998027207A1 (fr) | 1998-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6541258B2 (en) | AAV split-packaging genes and cell lines comprising such genes for use in the production of recombinant AAV vectors | |
CA2269661A1 (fr) | Cassettes d'encapsidation d'aav activables par la recombinase servant a la production de vecteurs d'aav | |
US6642051B1 (en) | Amplifiable adeno-associated virus(AAV) packaging cassettes for the production of recombinant AAV vectors | |
AU688428B2 (en) | Generation of high titers of recombinant AAV vectors | |
US20210010027A1 (en) | Compositions and methods for generating adeno-associated viral vectors with undetectable capsid gene contamination | |
US6924128B2 (en) | Packaging cell lines for generation of high titers of recombinant AAV vectors | |
AU707866B2 (en) | Packaging cell lines for generation of high titers of recombinant AAV vectors | |
WO1998027204A9 (fr) | Genes d'encapsidation fractionnes de virus adeno-associe (aav) et lignees cellulaires comprenant ces genes utilises pour la production de vecteurs d'aav de recombinaison | |
US6936466B2 (en) | Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors | |
US20040087026A1 (en) | Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof | |
JP2006223315A (ja) | Aavベクター産生のための高効率ヘルパー系 | |
WO1996017947A9 (fr) | Lignees cellulaires d'encapsidation utilisees pour la generation de titres hauts de vecteurs aav recombinants | |
AU749352B2 (en) | A conditional replication and expression system | |
AU758541B2 (en) | Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors | |
US7208315B2 (en) | Compositions and methods for efficient AAV vector production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |